Abstract
Patients with systemic lupus erythematosus (SLE) have an increased risk of serious infections due to intrinsic disturbances in their immune system, the use of immunosuppressive medications, and the potential presence of organ damage associated with their disease. Thus, this population is of particular concern with the pandemic disease of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) or (COVID-19). Several viral infections complicating the course of COVID-19 have been reported but sparsely.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
